State insulin resistance, the intensity of endogenous intoxication in patients with chronic pancreatitis against obesity treatment in the dynamics of L-carnitine and L-glutathione
DOI:
https://doi.org/10.14739/2310-1210.2016.6.85505Keywords:
chronic pancreatitis, obesity, L-carnitine, L-glutathione, pancreas, metabolic syndrome, endogenous intoxication, insulin resistanceAbstract
Aim. To study the L-carnitine and L-glutathione influence on the clinical course of chronic pancreatitis (CP) in patients with obesity.
Materials and methods. Three representative groups of patients were formed to determine the effectiveness of treatment. The average age of patients was (41.7±4.2) years. The common control group included 30 practically healthy persons (PHP) of the corresponding age and gender. The control group (group 1 (K), 25 persons), the basic group 2 (group 2 (A), 30 persons), the basic group 3 (group 3 (B) 25 persons).
Results. After applying the proposed therapy in CP patients (group b) in the course of the disease compared with the group K showed an improvement of health, reduction of asthenic-vegetative, intoxication, and dyspepsia syndromes signs. After 2 weeks of therapy asthenic-vegetative syndrome was absent. Analysis of indicators in 3 months after treatment indicated that patients of the 2nd and the 3rd were achieved stable remission of CP, as no patient visited doctors for medical aid again. But, in 3 months after treatment 2 patients of the K group (10%) were admitted again, 5 patients (25%) sought medical help repeatedly concerning exacerbation of CP symptoms to the gastroenterologists. The result of the complex therapy with L-glutathione and L-carnitine addition positive effect on the IR syndrome is defined in our study a significant decrease of body mass index in patients of the 2nd and the 3rd groups during a 60 days period respectively: 7.5% and 8.1% (p<0.05).
Conclusions. A specific method of patients’ treatment with CP on the background of obesity, which includes basic therapy together with the using of L-glutathione and L-carnitine combination, helps to eliminate clinical and biochemical signs of chronic pancreatitis exacerbation, to reduce the degree of endogenous intoxication, oxidative and nitro-oxidative stress, to normalize steadily the glycemic and insulin level, to reduce body weight.
References
Arhiy, E. Y., Moskal, O. M., & Mishanich, T. V. (2014) Khronichnyi pankreatyt, poiednanyi z ishemichnoiu khvoroboiu sertsia: osoblyvosti protsesiv travlennia ta interleikinovoho statusu [Chronic pancreatitis combined with coronary heart disease: peculiarities of the digestion process and interleukin status]. Naukovyi visnyk Uzhhorodskoho universytetu. Seriia «Medytsyna», 1(49), 24–27. [in Ukrainian].
Astashkin, E. I., & Glezer, M. G. (2012) Rol´ L-karnitina v e´nergeticheskom obmene kardiomiocytov i lechenii zabolevanij serdechno-sosudystoj sistemy [The role of L-carnitine in the energetic metabolism of cardiomyocytes and treatment of cardio-vascular diseases]. Kardiologiya i serdechno-sosudistaya khirurgiya, 2, 58–65. [in Russian].
Babak, O. Ya. (2015) Glutation v norme i pri patologii: biologicheskaya ro´l i vozmozhnosti klinicheskogo primeneniya [Glutathione in norm and at pathology: byolohycheskaya role of application and Clinical Opportunities]. Zdorovia Ukrainy. Tematychnyi nomer «Hastroenterolohiia. Hepatolohiia. Koloproktolohiia», 1, 1–3. [in Ukrainian].
Bondarenko, O. A. (2012) Klinicheskaya diagnostika hkronicheskogo pankreatita v sochetanii s ozhireniem [Clinical diagnostics of chronic pancreatitis in combination with obesity]. Ukrainskyi terapevtychnyi zhurnal, 3–4, 35–39. [in Ukrainian].
Zvyaginceva, T. D., & Glushchenko, S. V. (2015) L-karnitin i oksidativnyj stres – stress pri nealkogol´nom steatogepatite [L-carnitine and oksydat stress – stress with nonalcoholic steatohepatitis]. Doktor.RU, 2-2(103), 19–20. [in Russian].
Zvyaginceva, T. D., & Glushchenko, S. V. (2014) Znachenie L–karnitina i provospalitel´nykh citokinov v razvitii nealkogol´nogo steatogepatita [L-carnitine and proinflammatory cytokine in the development of NASH]. Novosti mediciny i farmacii, 20(522), 20–21_u. [in Russian].
Klyuiko, D. A., Korik, V. E., & Zhidkov, S. A. (2011) Sravnenie e´ffektivnosti antioksidantnykh preparatov primenitel´no k ostromu pankreatitu v e´ksperimente [Comparative Experimental Study of Antioxidant Efficiency in Treatment of Acute Pancreatitis] E´ksperimental´naya i klinicheskaya farmakologiya, 74(9), 11–15. [in Russian].
Moskal, O. M., Myshanych, T. V., & Arxij, E. J. (2014) Stan protsesiv travlennia ta riven interleikiniv pry khronichnomu pankreatyti, poiednanomu z ishemichnoiu khvoroboiu sertsia [State digestive processes and levels of interleukins in chronic pancreatitis combined with coronary heart disease]. Inter. medical journal, 1(1), 25–27. [in Ukrainian].
Bilovol, O. M., Kovalova, O. M., Popova, S. S., & Tveretinov, O. B. (2009) Ozhyrinnia v praktytsi kardioloha ta endokrynoloha [Obesity in practice cardiologist and endocrinologist]. Ternopil: Ukrmedknyha. [in Ukrainian].
Samsonova, N. G. (2007) Geneticheskie mekhanizmy abdominal´nogo ozhireniya [Genetic mechanisms of abdominal obesity] E´ksperimental'naya i klinicheskaya gastroe´nterologiya, 1, 34–38. [in Russian].
Fadeenko, G. D., Prosolenko, K. A., & Kolesnikova, E. V. (2008) Rol´ ozhireniya kak komponenta metabolicheskogo sindroma v vozniknovenii i progressirovanii nealkogol´noj zhirovoj bolezni pecheni [The role of obesity as a component of the metabolic syndrome in appearance and progression of nonalcoholic fatty liver disease]. Suchasna hastroenterolohiia, 2, 4–10. [in Ukrainian].
Khukhlina, O. S., Voyevidka, O. S., & Ursul, O. O. (2014) Osoblyvosti patohenezu vzaiemoobtiazhennia khronichnoho obstruktyvnoho zakhvoriuvannia lehen, khronichnoho pankreatytu za yikh komorbidnoho perebihu [Peculiarities of comorbid pathogenesis of chronic obstructive pulmonary disease and chronic pancreatitis]. Zdobutky klinichnoi ta eksperymentalnoi medytsyny, 1(20), 129–132. [in Ukrainian].
Khukhlina, O. S., Ursul, O. O., & Smandych, V. S. (2014) Porivniannia efektyvnosti plazmaferezu ta kompleksnoi protyoksydantnoi terapii u khvorykh iz poiednanym perebihom khronichnoho pankreatytu ta khronichnoho obstruktyvnoho zakhvoriuvannia lehen [Comparison of plasmapheresis efficacy and complex antioxidant therapy in patients with comorbid course of chronic pancreatitis and chronic obstructive pulmonary disease]. Bukovynskyi medychnyi visnyk, 18, 4(72), 164–168. [in Ukrainian].
Cheng, K.K.Y., Lam, K.S.L., Wang Y., Huang, Yu., Carling, D., Wu, D. et al. (2007) Adiponectin-induced endogene synthase activation and nitric oxide production are mediated by APPL 1 in endothelial cells. Diabetes, 56(4), 1387–1394. doi: 10.2337/db06-1580.
Ahima, R. (2007) Obesity: much silence makes a mighty noise. Gastroenter, 132, 2085–2086. doi: 10.1053/j.gastro.2007.03.060.
Ogden, C. L., Yanovski, S. Z., Carroll, M. D., & Flegal, K. M. (2007) The epidemiology of obesity. Gastroenterol, 132, 2087–2102. doi: 10.1053/j.gastro.2007.03.052.
Shafiq, N., Rana, S., Bhasin, D., Pandhi, P., Srivastava, P., Sehmby, S. S.,et al. (2009) Pancreatic enzymes for chronic pancreatitis. Cochrane Database of Systematic Reviews, 7(4), CD006302. doi: 10.1002/14651858.CD006302.pub2.
Yaghoobi, M., McNabb-Baltar, J., Bijarchi, R., & Cotton, P. B. (2016) Pancreatic enzyme supplements are not effective for relieving abdominal pain in patients with chronic pancreatitis: meta-analysis and systematic review of randomized controlled trials. Can. J. Gastroenterol. Hepatol, 4. doi: 10.1155/2016/8541839.
Bishop, M.D., Freedman, S. D., Zielenski, J., Ahmed, N., Dupuis, A., Martin, S., et al. (2005) The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Hum. Genet, 118(3), 372–381. doi: 10.1007/s00439-005-0059-z.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
